Peter Bryden

1.7k citations

19 papers · 1.2k indexed · 1 hit paper · h-index 11

Impact in

Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 5%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases

Papers in ⓘ

Clinical Psychology 5
- Obsessive-Compulsive Spectrum Disorders 4
- Eating Disorders and Behaviors 3
Genetics 3
- Chronic Lymphocytic Leukemia Research 3

Co-authors: Nicky J. Welton (10 shared papers)William Hollingworth (8 shared papers)Deborah M Caldwell (8 shared papers)Jonathan A C Sterne (4 shared papers)Aroon D. Hingorani (4 shared papers)Diane Eaton (4 shared papers)Julian P. T. Higgins (4 shared papers)Howard Thom (4 shared papers)
Journals: Value in Health (5 papers)Health Technology Assessment (3 papers)International Journal of Geomechanics (1 paper)PharmacoEconomics (1 paper)Lung Cancer (1 paper)
Partner nations: United Kingdom United States Canada

In The Last Decade

Peter Bryden

17 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis 2017 · 381 citations

Peers

Countries citing papers authored by Peter Bryden

Since Specialization

Citations

This map shows the geographic impact of Peter Bryden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bryden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bryden more than expected).

Fields of papers citing papers by Peter Bryden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bryden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bryden. The network helps show where Peter Bryden may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Bryden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Bryden Line = papers co-authored together Peter Bryden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis BMJ ·José A López-López, Jonathan A C Sterne, Howard Thom, Julian P. T. Higgins, Aroon D. Hingorani, George N. Okoli, Philippa Davies, Pritesh Bodalia, Peter Bryden, Nicky J. Welton, William Hollingworth, Deborah M Caldwell, Jelena Savović, Sofia Dias, Chris Salisbury, Diane Eaton, Annya Stephens-Boal, Reecha Sofat Hit paper breakdown →	2017	381
2	Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis The Lancet Psychiatry ·Petros Skapinakis, Deborah M Caldwell, William Hollingworth, Peter Bryden, Naomi Fineberg, Paul M. Šalkovskis, Nicky J. Welton, Helen Baxter, David Keßler, Rachel Churchill, Glyn Lewis	2016	239
3	Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis Health Technology Assessment ·Jonathan A C Sterne, Pritesh Bodalia, Peter Bryden, Philippa Davies, José A López-López, George N. Okoli, Howard Thom, Deborah M Caldwell, Sofia Dias, Diane Eaton, Julian P. T. Higgins, William Hollingworth, Chris Salisbury, Jelena Savović, Reecha Sofat, Annya Stephens-Boal, Nicky J. Welton, Aroon D. Hingorani	2017	145
4	Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis Health Technology Assessment ·Nicky J. Welton, Alexandra McAleenan, Howard Thom, Philippa Davies, William Hollingworth, Julian P. T. Higgins, George N. Okoli, Jonathan A C Sterne, Gene Feder, Diane Eaton, Aroon D. Hingorani, Christopher G. Fawsitt, Trudie Lobban, Peter Bryden, Alison Richards, Reecha Sofat	2017	103
5	A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive–compulsive disorder in children/adolescents and adults Health Technology Assessment ·Petros Skapinakis, Deborah M Caldwell, William Hollingworth, Peter Bryden, Naomi Fineberg, Paul M. Šalkovskis, Nicky J. Welton, Helen Baxter, David Keßler, Rachel Churchill, Glyn Lewis	2016	87
6	IMPRoving Outcomes for children exposed to domestic ViolencE (IMPROVE): an evidence synthesis SHILAP Revista de lepidopterología ·Emma Howarth, Theresa HM Moore, Nicky J. Welton, Natalia Lewis, Nicky Stanley, Harriet L. MacMillan, Alison Shaw, Marianne Hester, Peter Bryden, Gene Feder	2016	67
7	Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors Leukemia Research ·J. H. Lipton, Peter Bryden, M. Sidhu, Hui Huang, Lisa J. McGarry, Stephanie Lustgarten, Stuart Mealing, Beth Woods, Jo Whelan, Neil Hawkins	2014	38
8	Soil-Structure Interaction of Very Flexible Pipes: Centrifuge and Numerical Investigations International Journal of Geomechanics ·Peter Bryden, Hany El Naggar, Arun J. Valsangkar	2014	31
9	Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S. Lung Cancer ·Gayathri Kumar, Beth Woods, Lisa M. Hess, Joseph Treat, Mark E. Boye, Peter Bryden, Katherine B. Winfree	2015	17
10	Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales Value in Health ·Rachel Allen, Peter Bryden, Kelly M. Grotzinger, Ceilidh Stapelkamp, Beth Woods	2016	15
11	Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective PharmacoEconomics ·Emma Simpson, Sarah Davis, Praveen Thokala, Penny Breeze, Peter Bryden, Ruth Wong	2015	11
12	Confronting Heterogeneity: Using Systematic Review Effectively for Meta-Analysis Value in Health ·Joan Quigley, Beth Woods, J.C. Thompson, Peter Bryden, David A. Scott	2013	7
13	Relative efficacy and safety of simeprevir and telaprevir in treatment‐naïve hepatitis C‐infected patients in a Japanese population: A Bayesian network meta‐analysis Hepatology Research ·Joan Quigley, Peter Bryden, David A. Scott, Hiroyo Kuwabara, Karin Cerri	2015	7
14	Pharmacological and Psychotherapeutic Interventions for Management of Obsessive-compulsive Disorder in Adults: A Systematic Review and Network Meta-analysis FOCUS The Journal of Lifelong Learning in Psychiatry ·Petros Skapinakis, Deborah M Caldwell, William Hollingworth, Peter Bryden, Naomi Fineberg, Paul M. Šalkovskis, Nicky J. Welton, Helen Baxter, David Keßler, Rachel Churchill, Glyn Lewis	2021	4
15	Network Meta-Analysis of the Relative Efficacy of Pharmacological and Psychological Interventions in Adults with Obsessive Compulsive Disorder Value in Health ·Peter Bryden, Deborah M Caldwell, Nicky J. Welton, Rachel Churchill, Helen Baxter, Glyn Lewis, Petros Skapinakis	2014	1
16	A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintenance for Non-Squamous NSCLC in Sweden Value in Health ·Peter Bryden, C. G. Delhi Kumar, Katherine B. Winfree, Mark E. Boye, Kaisa Taipale, Richard J. Thompson, H. Borgeke	2013	1
17	A Cost-Effectiveness Analysis Of Novel Oral Anticoagulants For Acute Treatment And Secondary Prevention Of Venous Thromboembolic Disease Value in Health ·Peter Bryden, Nicky J. Welton, Howard Thom, Jonathan A C Sterne, Pritesh Bodalia, Philippa Davies, José A López-López, GN Okoli, Deborah M Caldwell, Sofia Dias, Diane Eaton, Julian P. T. Higgins, Chris Salisbury, Jelena Savović, Reecha Sofat, Annya Stephens-Boal, Aroon D. Hingorani, William Hollingworth	2015	1
18	Comparative Efficacy Among Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients After Failure Of 2nd Generation Tyrosine Kinase Inhibitors (2G TKIs) Blood ·Jeff H. Lipton, Peter Bryden, Manpreet Sidhu, Hui Huang, Lisa J. McGarry, Stephanie Lustgarten, Beth Woods, Neil Hawkins	2013	0
19	Quality assessment of trials Petros Skapinakis, Deborah M Caldwell, William Hollingworth, Peter Bryden, Naomi Fineberg, Paul M. Šalkovskis, Nicky J. Welton, Helen Baxter, David Kessler, Rachel Churchill, Glyn Lewis	2016	0

About Peter Bryden

Peter Bryden is a scholar working on Clinical Psychology, Genetics, Cardiology and Cardiovascular Medicine, Internal Medicine and Cognitive Neuroscience, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Obsessive-Compulsive Spectrum Disorders (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Autism Spectrum Disorder Research (3 papers), Eating Disorders and Behaviors (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Acute Ischemic Stroke Management (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Internal Medicine (220 citations), Cardiology and Cardiovascular Medicine (548 citations), Clinical Psychology (349 citations), Experimental and Cognitive Psychology (104 citations) and Hematology (79 citations). Peter Bryden has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Nicky J. Welton, William Hollingworth, Deborah M Caldwell, Jonathan A C Sterne, Aroon D. Hingorani, Diane Eaton, Julian P. T. Higgins, Howard Thom, Reecha Sofat and George N. Okoli. Their work appears in journals such as Value in Health, Health Technology Assessment, International Journal of Geomechanics, PharmacoEconomics and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact